Clinical Trials
3 trialsNCT00748189 2019-06-25
COMPLEMENT 1
Novartis
Phase 3 Terminated
NCT01563055 2015-08-10
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
GlaxoSmithKline
Phase 2 Completed
NCT01678430 2012-10-15
RIAltO
University of Liverpool
Phase 3 Unknown